Effect of Mad2 on Paclitaxel-induced Cell Death in Ovarian Cancer Cells
10.1007/s11596-010-0553-y
- Author:
HAO XING
1
;
ZHOU ZHIGANG
;
YE SHUANGMEI
;
ZHOU TING
;
LU YUNPING
;
MA DING
;
WANG SHIXUAN
Author Information
1. Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- Keywords:
paclitaxel resistance;
ovarian cancer;
Mad2;
Bcl-2
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2010;30(5):620-625
- CountryChina
- Language:Chinese
-
Abstract:
In this article, the status of spindle assembly checkpoint and the alteration of its major component, Mad2 protein level were examined in A2780 and SKOV3 ovarian cancer cell lines. Recombinant eukaryotic expression plasmid pEGFP-Mad2 was transfected into paclitaxel-resistant SKOV3 cells and Mad2 protein was knocked down by Mad2-specific siRNA in paclitaxel-sensitive A2780 cells. Then the expression level of Mad2 gene was detected by Western blotting. Flow cytometry revealed that SKOV3 cells were not fully arrested in G2/M phase in contrast to A2780 cells in the presence of paclitaxel. However, paclitaxel sensitivity assay showed that sensitivity to paclitaxel was reversed after the transfection in both cell lines in terms of number of cells arrested at G2/M phase and the expression of Bcl-2 was significantly changed. These results suggest that weakened spindle checkpoint with reduced expression of Mad2 is associated with resistance to paclitaxel in ovarian cells and Bcl-2 may be involved in this process.
